OPTN - OptiNose, Inc.
9.6
-0.110 -1.146%
Share volume: 860,961
Last Updated: 05-20-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$9.71
-0.11
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-14-2024 | 08-08-2024 | 11-12-2024 | 03-26-2025 | 05-14-2025 | |
| Cash flow financing | 7.000 K | 55.436 M | -7.000 K | 117.000 K | 0.000 | |
| Other financing cash flows | 0.000 | -205.000 K | 198.000 K | 0.000 | 0.000 | |
| Cash flow | -22.025 M | 39.713 M | -8.861 M | 0.000 | -11.552 M | |
| Net income | -14.067 M | -7.581 M | 467.000 K | -360.000 K | -22.416 M | |
| Depreciation | 83.000 K | 70.000 K | 65.000 K | 65.000 K | 64.000 K | |
| Changes in inventories | 10.315 M | 0.000 | 0.000 | 0.000 | -163.000 K | |
| Changes in receivables | 14.227 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -22.000 K | -29.000 K | -21.000 K | 0.000 | 0.000 | |
| Net Borrowings | 74.073 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -22.000 K | 29.000 K | 21.000 K | 0.000 | 0.000 | |
| Cash Change | 51.644 M | 39.713 M | -8.861 M | 1.989 M | -11.552 M |